阿凡达

Chinese researchers identify target to develop depression drug using traditional ethnic medicine in Yunnan_我的网站

一 |     

    Qingyangshen, or Root of Auricledleaf Swallowwort, a traditional ethnic medicinal plant long used in Southwest China's Yunnan Province. Photo: Scrrenshot from website
A Chinese research team has identified a new potential target to develop antidepressant drug from Qingyangshen, or Root of Auricledleaf Swallowwort, a traditional ethnic medicinal plant long used in Southwest China's Yunnan Province, according to Kunming University of Science and Technology, Science and Technology Daily reported Sunday.
The team, led by professors Xu Tianrui and Xiang Cheng from the university's School of Life Science and Technology, found that Qingyangshen glycosides, the plant's core active compound, can alleviate depression-related behaviors by simultaneously suppressing inflammation, reducing oxidative damage and stabilizing neurotransmitters in the brain.
The findings were published in the international journal Phytomedicine.  
Depression has become a widespread mental health disorder globally, while existing clinical drugs fail to provide effective treatment for more than 30 percent of patients, according to the researchers. Previous studies have established a strong link between chronic inflammation and depression, but existing anti-inflammatory drugs have limited targeting capabilities, underscoring the need for new therapeutic targets and lead compounds.
Qingyangshen, a plant of the Cynanchum genus in the Apocynaceae family, has long been used as a traditional medicine by ethnic groups including the Naxi, Yi and Bai peoples in Yunnan, mainly for treating neurological conditions such as epilepsy and neurasthenia. 
The researchers systematically examined the pharmacological effects of Qingyangshen extract and its core active compound, Qingyangshen glycosides. Tests using mouse, zebrafish and fruit fly models repeatedly showed that the compound significantly improved depression-related behaviors induced by inflammation, according to the report.
To identify the compound's target, the team developed a dual-discrimination model for four subtypes of prostaglandin E2 receptors and combined it with AI-powered machine learning. The researchers screened hundreds of G protein-coupled receptors and identified the prostaglandin E2 subtype 4 receptor as the direct target of Qingyangshen glycosides.
Multiple molecular experiments confirmed that the compound binds directly to the receptor and acts as an inhibitory ligand. Further experiments involving animals with the receptor knocked out in the hippocampus showed that the antidepressant effects of Qingyangshen glycosides disappeared completely when the receptor was absent, providing the first in-vivo evidence that the receptor is essential for the compound's therapeutic effects.
    An illustration of the research. Photo: Screenshot from the website
The study establishes the prostaglandin E2 subtype 4 receptor as a potential new target for antidepressant drug development and points to a new approach to treating depression through inflammatory pathways. It also identifies Qingyangshen glycosides as a potential lead compound for developing highly targeted anti-inflammatory antidepressants, creating a research chain from ethnic medicinal plants and active compounds to drug targets and new drug development.
Global Times
。2018年12月21日，苹果iPhone和iPad用户迎来了微信iOS 7.0.0版的更新，带来了新版本的界面，更清晰直观的视觉和操作体验；您可以浏览朋友认为不错的文章；您可以在聊天详情页面设置单次聊天的强烈提醒。此外，还增加了“时间视频”功能，可以为朋友的视频制作一个泡泡。随后，Android用户于2018年12月30日正式推出微信7.0更新。

二 | 但用户普遍认为土套新版微信“太白”、“亮盲”和“丑”。在微信7.0的界面修改问题上，腾讯集团高级执行副总裁、微信集团总裁张小龙在今天举行的2019微信公开课上对专业“微信之夜”做出了回应。在他的“微信之夜”演讲中，张小龙谈到了微信7.0的“丑陋界面”，并说，“产品需要适应这个时代，而不是说我们的用户抱怨，他们不会改变它。

三 | ”此外，当张小龙谈到微信首页为什么没有广告时，他说，如果把微信与自己的相比朋友，那么在开始页上的广告就像是在他最好的朋友的脸上贴广告。最后，张小龙还表示，用户停留时间的长短不应被视为应用产品的价值目标。我们仍然主张人们放下手机，花更多的时间和家人在一起。

Current article:http://www.zuanniangwandangliaolinechu.sbs/886g/1bw.xlsx

Published on:08:42:11